Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjun Qiu

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Genetics|March 14, 2022
Complex Chromosomal Rearrangement Causes Male Azoospermia: A Case Report and Literature ReviewYi Liang, Yingjun Xie, Shu Kong, et al.
Biology|January 10, 2026
Effects of Glutamine Dipeptide-Supplemented Formulated Diet Substituting Chilled Trash Fish in Chinese Mitten Crab (<i>Eriocheir sinensis</i>)Wenjun Qiu, Xueming Hua, Bin Luo, et al.
International Journal of Clinical and Experimental Pathology|March 11, 2015
Role of growth differentiation factor-5 and bone morphogenetic protein type II receptor in the development of lumbar intervertebral disc degenerationYi-Fan Li, Xian-Zhong Tang, Chao-Ge Liang, et al.
Clinical Science (London, England : 1979)|July 6, 2026
Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosisFengming Guo, Yuxin Liu, Wenjun Qiu, et al.
Journal of Translational Medicine|September 9, 2021
Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy responseJiani Wu, Dongqiang Zeng, Shimeng Zhi, et al.
Expert Opinion on Drug Safety|February 26, 2025
Post-marketing safety surveillance of Amivantamab: a real world study based on the FDA adverse event reporting systemXiang Fu, Dongqiang Zeng, Min Li, et al.
Frontiers in Immunology|July 19, 2021
IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and SignaturesDongqiang Zeng, Zilan Ye, Rongfang Shen, et al.
Iscience|February 20, 2026
Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancerJiani Wu, Yuanyuan Wang, Zhenhua Huang, et al.
Cell Reports Methods|December 3, 2024
Enhancing immuno-oncology investigations through multidimensional decoding of tumor microenvironment with IOBR 2.0Dongqiang Zeng, Yiran Fang, Wenjun Qiu, et al.
Iscience|December 17, 2024
Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancerJiani Wu, Yuanyuan Wang, Zhenhua Huang, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Genetics|March 14, 2022
Complex Chromosomal Rearrangement Causes Male Azoospermia: A Case Report and Literature ReviewYi Liang, Yingjun Xie, Shu Kong, et al.
Biology|January 10, 2026
Effects of Glutamine Dipeptide-Supplemented Formulated Diet Substituting Chilled Trash Fish in Chinese Mitten Crab (<i>Eriocheir sinensis</i>)Wenjun Qiu, Xueming Hua, Bin Luo, et al.
International Journal of Clinical and Experimental Pathology|March 11, 2015
Role of growth differentiation factor-5 and bone morphogenetic protein type II receptor in the development of lumbar intervertebral disc degenerationYi-Fan Li, Xian-Zhong Tang, Chao-Ge Liang, et al.
Clinical Science (London, England : 1979)|July 6, 2026
Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosisFengming Guo, Yuxin Liu, Wenjun Qiu, et al.
Journal of Translational Medicine|September 9, 2021
Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy responseJiani Wu, Dongqiang Zeng, Shimeng Zhi, et al.
Expert Opinion on Drug Safety|February 26, 2025
Post-marketing safety surveillance of Amivantamab: a real world study based on the FDA adverse event reporting systemXiang Fu, Dongqiang Zeng, Min Li, et al.
Frontiers in Immunology|July 19, 2021
IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and SignaturesDongqiang Zeng, Zilan Ye, Rongfang Shen, et al.
Iscience|February 20, 2026
Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancerJiani Wu, Yuanyuan Wang, Zhenhua Huang, et al.
Cell Reports Methods|December 3, 2024
Enhancing immuno-oncology investigations through multidimensional decoding of tumor microenvironment with IOBR 2.0Dongqiang Zeng, Yiran Fang, Wenjun Qiu, et al.
Iscience|December 17, 2024
Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancerJiani Wu, Yuanyuan Wang, Zhenhua Huang, et al.
Pageof 4